4.6 Article

Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide

期刊

NANOTECHNOLOGY
卷 21, 期 30, 页码 -

出版社

IOP PUBLISHING LTD
DOI: 10.1088/0957-4484/21/30/305102

关键词

-

资金

  1. Minnesota Partnership for translational Nanotechnology in Cancer [UOFMN-MEDICA 5P1, UOFMN-MEDICA 5CA]
  2. NIH [R01 DK 59615, R01 HL 86990, P30 DK 084567]
  3. Mayo Clinic Center

向作者/读者索取更多资源

Nitric oxide (NO) plays an important role in inhibiting the development of hepatic fibrosis and its ensuing complication of portal hypertension by inhibiting human hepatic stellate cell (HSC) activation. Here we have developed a gold nanoparticle and silica nanoparticle mediated drug delivery system containing NO donors, which could be used for potential therapeutic application in chronic liver disease. The gold nanoconjugates were characterized using several physico-chemical techniques such as UV-visible spectroscopy and transmission electron microscopy. Silica nanoconjugates were synthesized and characterized as reported previously. NO released from gold and silica nanoconjugates was quantified under physiological conditions (pH = 7.4 at 37 degrees C) for a substantial period of time. HSC proliferation and the vascular tube formation ability, manifestations of their activation, were significantly attenuated by the NO released from these nanoconjugates. This study indicates that gold and silica nanoparticle mediated drug delivery systems for introducing NO could be used as a strategy for the treatment of hepatic fibrosis or chronic liver diseases, by limiting HSC activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Cxcr6-Based Mesenchymal Stem Cell Gene Therapy Potentiates Skin Regeneration in Murine Diabetic Wounds

Neha R. Dhoke, Komal Kaushik, Amitava Das

MOLECULAR THERAPY (2020)

Article Oncology

Concise Synthesis of 1,1-Diarylvinyl Sulfones and Investigations on their Anti-proliferative Activity via Tubulin Inhibition

Lavanya Reddy, Suja T. Dharmabalan, Kanakaraju Manupati, Ragini Yeeravalli, Lakshmi D. Vijay, Kavitha Donthiboina, Vadithe Lakshma Naik, Amitava Das

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)

Review Oncology

Recent Advances on Epidermal Growth Factor Receptor as a Molecular Target for Breast Cancer Therapeutics

Swathi R. Shetty, Ragini Yeeravalli, Tanya Bera, Amitava Das

Summary: EGFR, a crucial transmembrane protein with tyrosine kinase activity, is overexpressed in various cancers triggering tumor progression and drug resistance; Inhibition of EGFR modulates chemosensitivity in breast cancer stem cells, serving as a potential drug target for breast cancer mitigation; Tyrosine kinase inhibitors and monoclonal antibodies targeting EGFR have been developed and approved for clinical use against breast cancer.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Review Cell & Tissue Engineering

Advances in generation of three-dimensional skin equivalents: pre-clinical studies to clinical therapies

Subholakshmi Choudhury, Amitava Das

Summary: This article highlights the latest approaches in developing skin equivalents, different models for studying skin diseases and properties, as well as current therapeutic applications of skin substitutes.

CYTOTHERAPY (2021)

Article Cell Biology

Recent advances in the induced pluripotent stem cell-based skin regeneration

Subholakshmi Choudhury, Nidhi Surendran, Amitava Das

Summary: The review discusses the current treatment strategies for chronic wounds and challenges, as well as the application of iPSC technology in the field of regenerative therapy. It also highlights the advantages of using iPSCs for skin cell generation and skin disease modeling over existing clinical therapies.

WOUND REPAIR AND REGENERATION (2021)

Article Biochemistry & Molecular Biology

TWIST1-mediated transcriptional activation of PDGFR beta in breast cancer stem cells promotes tumorigenesis and metastasis

Ragini Yeeravalli, Komal Kaushik, Amitava Das

Summary: The study demonstrates the crucial role of PDGFR beta in regulating EMT in breast CSCs, leading to increased physiological and molecular properties in breast cancer cells and CSCs with PDGFR beta overexpression. Mechanistically, PDGFR beta overexpression induces FAK and Src activation, promoting cell migration and invasion. Stable silencing of PDGFR beta disrupts these biological phenomena and could be a potential therapeutic target for treating TNBC patients.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Biochemistry & Molecular Biology

Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis

Kanakaraju Manupati, Ragini Yeeravalli, Komal Kaushik, Digvijay Singh, Bhupendra Mehra, Nitin Gangane, Anupama Gupta, Kalyan Goswami, Amitava Das

Summary: Breast cancer stem cells with high CD44 expression play a key role in tumorigenesis by activating PSTAT3, SNAI3, and LPL genes. Inhibiting CD44 or targeting LPL can effectively prevent tumor progression and neoangiogenesis.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Cell Biology

SNAI1-mediated transcriptional regulation of epithelial-to-mesenchymal transition genes in breast cancer stem cells

Digvijay Singh, Rohit K. Deshmukh, Amitava Das

Summary: The study identified the crucial role of SNAI1 in inducing the expression of differentially expressed genes in breast cancer cells, leading to increased migration, invasion, and in vitro tumorigenesis, comparable to TNBC. The activation of breast cancer stem cell (CSC) phenotypes mediated by SNAI1 was perturbed by inhibiting downstream target MMPs, highlighting the importance of MMPs in SNAI1-mediated EMT regulation.

CELLULAR SIGNALLING (2021)

Article Biochemistry & Molecular Biology

Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters

Surbhi Shivhare, Amitava Das

Summary: This study found that breast cancer cells grown at low seeding density exhibit chemoresistance to doxorubicin or tamoxifen. In addition, the use of ABC transporter inhibitors can enhance the efficacy of chemotherapy drugs.

MOLECULAR BIOLOGY REPORTS (2023)

Article Medicine, Research & Experimental

Preclinical-to-clinical innovations in stem cell therapies for liver regeneration

Shilpa Chawla, Amitava Das

Summary: Acute and chronic liver diseases are leading causes of illness and death worldwide. While liver transplantation is a commonly used treatment for liver failure, the scarcity of liver donors has prompted the exploration of alternative approaches, such as cell-based regenerative medicine. Recent advancements in stem cell differentiation and liver tissue engineering have shown promise in generating effective therapies for liver regeneration. The development of bioengineered liver organoids holds great potential in treating liver injuries caused by chronic liver diseases.

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

ZEB1 potentiates chemoresistance in breast cancer stem cells by evading apoptosis

Surbhi Shivhare, Subholakshmi Choudhury, Digvijay Singh, Amitava Das

Summary: Chemoresistance presents a challenge in treating breast cancer patients. The zinc finger E-box binding homeobox 1 (ZEB1) transcription factor plays a key role in regulating breast cancer stem cells (CSCs) and their chemoresistance. In-silico analysis showed that high ZEB1 expression in breast cancer patients is associated with lower survival rates. Experimental results further demonstrated that overexpression of ZEB1 in breast CSCs correlated with increased drug resistance and decreased apoptosis. Targeting ZEB1 and its downstream effectors may be a potential therapeutic approach for overcoming chemoresistance in breast cancer patients.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2023)

Review Cell Biology

Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies

Sowmya Mekala, Prachi Dugam, Amitava Das

Summary: Hepatic fibrosis is a common pathological change caused by increased synthesis and accumulation of extracellular matrix components. Chronic insult from hepatotoxicants leads to liver cirrhosis and if not treated in time, liver transplantation is the only effective therapy. Moreover, the disease often progresses into hepatic carcinoma. Understanding the novel molecular signaling mechanisms involved in the disease progression would help develop effective therapeutics.

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2023)

Article Biotechnology & Applied Microbiology

In vitro and in silico antioxidant and antiproliferative activity of rhizospheric fungus Talaromyces purpureogenus isolate-ABRF2

Mahendra Kumar Sahu, Komal Kaushik, Amitava Das, Harit Jha

BIORESOURCES AND BIOPROCESSING (2020)

Article Biotechnology & Applied Microbiology

S-Nitroso-N-Acetyl-D-Penicillamine Modified Hyperbranched Polyamidoamine for High-Capacity Nitric Oxide Storage and Release

Sean P. Hopkins, Megan C. Frost

BIOENGINEERING-BASEL (2020)

暂无数据